Article

Coffee Has a Positive Influence on Gout Risk

Wouldn’t it be a dream come true if coffee consumption possibly helped reduce the risk of gout?

Wouldn’t it be a dream come true if coffee consumption possibly helped reduce the risk of gout?

Gout is a form of arthritis that more commonly affects men, especially between the ages of 40 and 50, than women. High uric acid blood test results could indicate the condition, in which case patients would be treated to lower the levels. Previous research has analyzed coffee’s impact on serum uric acid, but the findings have been conflicting.

Researchers from Korea took a stab at uncovering the correlation in the first systematic analysis of its kind published in Seminars in Arthritis & Rheumatism. The team reviewed nine studies totaling 175,310 participants between 1999 and 2014.

  • MD Magazine is on Facebook, Twitter, Instagram, and LinkedIn!

It turns out that one cup of coffee a day or more had a significant association with a reduced risk of gout. Serum uric acid levels were significantly lowered when women drank four to six cups a day and when men drank one to three. Therefore, it appears that women need to consume more coffee in order to reap the same gout preventive benefits as men.

“Based on our study, moderate coffee intake might be advocated for primary prevention of hyperuricemia and gout in both genders,” the authors confirmed. They did not touch on why coffee has this impact, but the analysis was presented at the 2015 ACR/ARHP Annual Meeting in San Francisco in November.

So if you needed another reason to refill your mug, consider it done and don’t hesitate to reach for the coffee pot.

What to Read Next >>> Most Patients with Gout Don’t Know Their Serum Urate Goal

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.